Stockreport

Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary

PRECISION THERAPEUTICS INC COMMON  (AIPT) 
US:NASDAQ Investor Relations: investors.skylinemedical.com/investor-relations
PDF MINNEAPOLIS, April 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, a company focused o [Read more]